Enhancers are major targets for murine leukemia virus vector integration

Journal of Virology

Volumn 88, Issue 8, 2014, Pages 4504-4513

  De Ravin, Suk See ^a   Su, Ling ^b   Theobald, Narda ^a   Choi, Uimook ^a   MacPherson, Janet L ^c,e   Poidinger, Michael ^c,f   Symonds, Geoff ^c,g   Pond, Susan M ^c,h   Ferris, Andrea L ^d   Hughes, Stephen H ^d   Malech, Harry L ^a   Wu, Xiaolin ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c JOHNSON AND JOHNSON   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF SYDNEY   (Australia)

^f AGENCY FOR SCIENCE   (Singapore)

^g Calimmune Australia Inc   (United States)

^h UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADULT; ANIMAL TISSUE; ARTICLE; CD34 SELECTION; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION; GENE MAPPING; GENETIC ASSOCIATION; HEMATOPOIETIC STEM CELL; HISTONE MODIFICATION; HUMAN; HUMAN CELL; LONG TERMINAL REPEAT; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION SITE; VIRUS GENE;

ANIMALS; CELLS, CULTURED; ENHANCER ELEMENTS, GENETIC; GENETIC THERAPY; GENETIC VECTORS; GENOME, HUMAN; HEMATOPOIETIC STEM CELLS; HISTONES; HUMANS; LEUKEMIA VIRUS, MURINE; MICE; MUTAGENESIS, INSERTIONAL; VIRUS INTEGRATION;

EID: 84896982583     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00011-14     Document Type: Article

References (35)

1. Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A, Morillon E, Clappier E, Caccavelli L, Delabesse E, Beldjord K, AsnafiV, MacIntyre E, Dal Cortivo L, Radford I, Brousse N, Sigaux F, Moshous D, Hauer J, Borkhardt A, Belohradsky BH, Wintergerst U, Velez MC, Leiva L, Sorensen R, Wulffraat N, Blanche S, Bushman FD, Fischer A, Cavazzana-Calvo M. 2008. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Investig. 118:3132-3142. http://dx.doi.org/10.1172/JCI35700.
2. Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H, Brugman MH, Pike-Overzet K, Chatters SJ, de Ridder D, Gilmour KC, Adams S, Thornhill SI, Parsley KL, Staal FJ, Gale RE, Linch DC, Bayford J, Brown L, Quaye M, Kinnon C, AncliffP, Webb DK, Schmidt M, von Kalle C, Gaspar HB, Thrasher AJ. 2008. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Investig. 118: 3143-3150. http://dx.doi.org/10.1172/JCI35798.
3. Witzel MGW, Braun CJ, Boztug K, Paruzynski A, Albert MH, Schwarzer A, Modlich U, Beier R, Göhring G, Naundorf S, Kühlcke K, Rose M, Fraser C, Mathias L, Ferrari R, Abboud MR, Al-Herz W, Kondratenko I, Maródi L, Schlegelberger B, Baum C, Schmidt M, von Kalle C, Klein C. 2013. Hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome. Blood 122:718. http://bloodjournal.hematologylibrary.org/content/122/21/718.abstract.
4. Ott MG, Schmidt M, Schwarzwaelder K, Stein S, Siler U, Koehl U, Glimm H, Kuhlcke K, Schilz A, Kunkel H, Naundorf S, Brinkmann A, Deichmann A, Fischer M, Ball C, Pilz I, Dunbar C, Du Y, Jenkins NA, Copeland NG, Luthi U, Hassan M, Thrasher AJ, Hoelzer D, von Kalle C, Seger R, Grez M. 2006. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12:401-409. http://dx.doi.org/10.1038/nm1393.
5. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. 2002. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110:521-529. http://dx.doi.org/10.1016/S0092-8674(02)00864-4.
6. CiuffiA, Llano M, Poeschla E, Hoffmann C, Leipzig J, Shinn P, Ecker JR, Bushman F. 2005. A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med. 11:1287-1289. http://dx.doi.org/10.1038/nm1329.
7. Cherepanov P, Ambrosio AL, Rahman S, Ellenberger T, Engelman A. 2005. Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc. Natl. Acad. Sci. U. S. A. 102:17308-17313. http://dx.doi.org/10.1073/pnas.0506924102.
8. Wu X, Li Y, Crise B, Burgess SM. 2003. Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749-1751. http://dx.doi.org/10.1126/science.1083413.
9. Gupta SS, Maetzig T, Maertens GN, Sharif A, Rothe M, Weidner-Glunde M, Galla M, Schambach A, Cherepanov P, Schulz TF. 2013. Bromo-and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration. J. Virol. 87:12721-12736. http://dx.doi.org/10.1128/JVI.01942-13.
10. De Rijck J, de Kogel C, Demeulemeester J, Vets S, El Ashkar S, Malani N, Bushman FD, Landuyt B, Husson SJ, Busschots K, Gijsbers R, Debyser Z. 2013. The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites. Cell Rep. 5:886-894. http://dx.doi.org/10.1016/j.celrep.2013.09.040.
11. Sharma A, Larue RC, Plumb MR, Malani N, Male F, Slaughter A, Kessl JJ, Shkriabai N, Coward E, Aiyer SS, Green PL, Wu L, Roth MJ, Bushman FD, Kvaratskhelia M. 2013. BET proteins promote efficient murine leukemia virus integration at transcription start sites. Proc. Natl. Acad. Sci. U. S. A. 110:12036-12041. http://dx.doi.org/10.1073/pnas.1307157110.
12. Studamire B, GoffSP. 2008. Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors. Retrovirology 5:48. http://dx.doi.org/10.1186/1742-4690-5-48.
13. Kanno T, Kanno Y, Siegel RM, Jang MK, Lenardo MJ, Ozato K. 2004. Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. Mol. Cell 13:33-43. http://dx.doi.org/10.1016/S1097-2765(03)00482-9.
14. Nakamura Y, Umehara T, Nakano K, Jang MK, Shirouzu M, Morita S, Uda-Tochio H, Hamana H, Terada T, Adachi N, Matsumoto T, Tanaka A, Horikoshi M, Ozato K, Padmanabhan B, Yokoyama S. 2007. Crystal structure of the human BRD2 bromodomain: insights into dimerization and recognition of acetylated histone H4. J. Biol. Chem. 282:4193-4201. http://dx.doi.org/10.1074/jbc. M605971200.
15. Hnilicova J, HozeifiS, Stejskalova E, Duskova E, Poser I, Humpolickova J, Hof M, Stanek D. 2013. The C-terminal domain of Brd2 is important for chromatin interaction and regulation of transcription and alternative splicing. Mol. Biol. Cell 24:3557-3568. http://dx.doi.org/10.1091/mbc. E13-06-0303.
16. Kang EM, Choi U, Theobald N, Linton G, Long Priel DA, Kuhns D, Malech HL. 2010. Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils. Blood 115:783-791. http://dx.doi.org/10.1182/blood-2009-05-222760.
17. Zhou S, Mody D, DeRavin SS, Hauer J, Lu T, Ma Z, Hacein-Bey Abina S, Gray JT, Greene MR, Cavazzana-Calvo M, Malech HL, Sorrentino BP. 2010. A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells. Blood 116:900-908. http://dx.doi.org/10.1182/blood-2009-10-250209.
18. Throm RE, Ouma AA, Zhou S, Chandrasekaran A, Lockey T, Greene M, De Ravin SS, Moayeri M, Malech HL, Sorrentino BP, Gray JT. 2009. Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection. Blood 113: 5104-5110. http://dx.doi.org/10.1182/blood-2008-11-191049.
19. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, Liu XS. 2008. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9:R137. http://dx.doi.org/10.1186/gb-2008-9-9-r137.
20. Quinlan AR, Hall IM. 2010. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26:841-842. http://dx.doi.org/10.1093/bioinformatics/btq033.
21. Roth SL, Malani N, Bushman FD. 2011. Gammaretroviral integration into nucleosomal targetDNAin vivo. J. Virol. 85:7393-7401. http://dx.doi.org/10.1128/JVI.00635-11.
22. Hon GC, Hawkins RD, Ren B. 2009. Predictive chromatin signatures in the mammalian genome. Hum. Mol. Genet. 18:R195-R201. http://dx.doi.org/10.1093/hmg/ddp409.
23. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. 2007. High-resolution profiling of histone methylations in the human genome. Cell 129:823-837. http://dx.doi.org/10.1016/j.cell.2007.05.009.
24. Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, Kellis M, Marra MA, Beaudet AL, Ecker JR, Farnham PJ, Hirst M, Lander ES, Mikkelsen TS, Thomson JA. 2010. The NIH Roadmap Epigenomics Mapping Consortium. Nat. Biotechnol. 28:1045-1048. http://dx.doi.org/10.1038/nbt1010-1045.
25. Wang GP, CiuffiA, Leipzig J, Berry CC, Bushman FD. 2007. HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res. 17:1186-1194. http://dx.doi.org/10.1101/gr.6286907.
26. Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese MP, Baricordi C, Dionisio F, Calabria A, Giannelli S, Castiello MC, Bosticardo M, Evangelio C, Assanelli A, Casiraghi M, Di Nunzio S, Callegaro L, Benati C, Rizzardi P, Pellin D, Di Serio C, Schmidt M, Von Kalle C, Gardner J, Mehta N, Neduva V, Dow DJ, Galy A, Miniero R, Finocchi A, Metin A, Banerjee PP, Orange JS, Galimberti S, Valsecchi MG, BiffiA, Montini E, Villa A, Ciceri F, Roncarolo MG, Naldini L. 2013. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 341:1233151. http://dx.doi.org/10.1126/science.1233151.
27. BiffiA, Montini E, Lorioli L, Cesani M, Fumagalli F, Plati T, Baldoli C, Martino S, Calabria A, Canale S, Benedicenti F, Vallanti G, Biasco L, Leo S, Kabbara N, Zanetti G, Rizzo WB, Mehta NA, Cicalese MP, Casiraghi M, Boelens JJ, Del Carro U, Dow DJ, Schmidt M, Assanelli A, Neduva V, Di Serio C, Stupka E, Gardner J, von Kalle C, Bordignon C, Ciceri F, Rovelli A, Roncarolo MG, Aiuti A, Sessa M, Naldini L. 2013. Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341:1233158. http://dx.doi.org/10.1126/science.1233158.
28. Eidahl JO, Crowe BL, North JA, McKee CJ, Shkriabai N, Feng L, Plumb M, Graham RL, Gorelick RJ, Hess S, Poirier MG, Foster MP, Kvaratskhelia M. 2013. Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes. Nucleic Acids Res. 41:3924-3936. http://dx.doi.org/10.1093/nar/gkt074.
29. Cattoglio C, Pellin D, Rizzi E, Maruggi G, Corti G, Miselli F, Sartori D, Guffanti A, Di Serio C, Ambrosi A, De Bellis G, Mavilio F. 2010. High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors. Blood 116:5507-5517. http://dx.doi.org/10.1182/blood-2010-05-283523.
30. Biasco L, Ambrosi A, Pellin D, Bartholomae C, Brigida I, Roncarolo MG, Di Serio C, von Kalle C, Schmidt M, Aiuti A. 2011. Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell. EMBOMol. Med. 3:89-101. http://dx.doi.org/10.1002/emmm.201000108.
31. Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA, Boyer LA, Young RA, Jaenisch R. 2010. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. U. S. A. 107:21931-21936. http://dx.doi.org/10.1073/pnas.1016071107.
32. Creyghton MP, Markoulaki S, Levine SS, Hanna J, Lodato MA, Sha K, Young RA, Jaenisch R, Boyer LA. 2008. H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment. Cell 135:649-661. http://dx.doi.org/10.1016/j.cell.2008.09.056.
33. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M, Ku M, Durham T, Kellis M, Bernstein BE. 2011. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473:43-49. http://dx.doi.org/10.1038/nature09906.
34. Shahbazian MD, Grunstein M. 2007. Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem. 76:75-100. http://dx.doi.org/10.1146/annurev.biochem.76.052705.162114.
35. Zhang W, Prakash C, Sum C, Gong Y, Li Y, Kwok JJ, Thiessen N, Pettersson S, Jones SJ, Knapp S, Yang H, Chin KC. 2012. Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J. Biol. Chem. 287:43137-43155. http://dx.doi.org/10.1074/jbc. M112.413047.